Risk of secondary leukemia after treatment with etoposide (VP-16) for Langerhans' cell histiocytosis in Italian and Austrian-German populations. (Q50963043)
Jump to navigation
Jump to search
scientific article published in March 1997
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Risk of secondary leukemia after treatment with etoposide (VP-16) for Langerhans' cell histiocytosis in Italian and Austrian-German populations. |
scientific article published in March 1997 |
Statements
1 reference
Risk of secondary leukemia after treatment with etoposide (VP-16) for Langerhans' cell histiocytosis in Italian and Austrian-German populations. (English)
1 reference
R Haupt
1 reference
T R Fears
1 reference
A Heise
1 reference
H Gadner
1 reference
G Loiacono
1 reference
M De Terlizzi
1 reference
M A Tucker
1 reference
1 March 1997
1 reference
71
1 reference
1
1 reference
9-13
1 reference
Identifiers
1 reference